Supportive housing program for people with HIV
Official title: A Type 1 Hybrid Effectiveness-Implementation Evaluation of a City-Level Transitional Housing Program's Effects on Health, Economic, and Psychologic Outcomes Among People With HIV
Run by University of Pennsylvania · NCT06829394 · Data updated 2026-11-12
This study is testing a supportive housing program for people with HIV to see if it helps them manage their health better and stay in stable housing.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 2 sites (Philadelphia, Pennsylvania and 1 other locations) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | January 2028 |
| Study ends | August 2028 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT06829394 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals living with HIV who are experiencing homelessness or severe housing instability.
✕Probably not a fit
Patients who are not experiencing housing instability or who do not meet the inclusion criteria will likely not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the Arms Around You (AAY) program, a supportive housing initiative aimed at addressing housing instability among people with HIV. Utilizing a Housing First model, the program provides rent support, medical case management, and housing counseling to improve HIV-related outcomes such as viral suppression and ART adherence. Participants are randomly assigned to receive immediate access to the program or to a waitlist, allowing researchers to compare health and economic outcomes over 36 months. Data will be collected through surveys, pharmacy records, and interviews to assess the program's feasibility and impact.
Why it matters
Potential benefit: If successful, this program could significantly improve health outcomes for people with HIV by enhancing their housing stability and access to care.
How similar studies have gone: Other studies have shown that supportive housing interventions can improve health outcomes for vulnerable populations, suggesting a promising approach for this initiative.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria for the Lottery Population will be all PWH in priority groups 1 or 2 included in the initial lottery for access to the AAY program. Inclusion criteria for the Survey population is (1) eligible for the HIV transitional housing program (2) priority group 1 or 2 with anticipated inclusion in the initial lottery (3) no plans to leave Philadelphia in the next year (4) regular access to a telephone to be able to complete phone surveys (5) able to provide informed consent. \- Exclusion Criteria: Does not meet the above inclusion criteria. \-
Where it's running
-
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Not yet recruiting
Study contacts
- Study coordinator: Aaron Richterman, MD, MPH
- Email: Aaron.Richterman@Pennmedicine.upenn.edu
- Phone: 267-441-7915
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Identifying HIV Drug Resistance Mutations in Mozambique
This study is trying to see if people with uncontrolled HIV who are on treatment develop changes in the virus that make their medications less effective.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.